Parsonage-Turner syndrome (PTS), also known as idiopathic brachial plexopathy or neuralgic amyotrophy, was first described by Julius Dreschfeld in 1887 PTS is characterized by a single or multiple mononeuropathies at the level of the brachial plexus (not exclusive), acute and self-limited, associated with motor deficit and muscle atrophy The exact pathophysiology is still unknown Of the many proposed causes, an infectious or immune-mediated process seems to be the most supported Viral illness is the most common associated risk factor (25% to 55%) Currently, there are only three case reports in the literature on the relation of COVID-19 with PTS The COVID- 19 neurological involvement has been described mainly at the central nervous system, with Guillain-Barré syndrome being the most frequent at the peripheral nervous system In the context of a coronavirus pandemic, we should suspect this disease in patients with neuropathic pain in the shoulder region within the possible differential diagnoses This publication is about a case of PTS in association with COVID-19 and a review of scientific literature available
Parsonage-Turner syndrome association with SARS-CoV-2 infection